Outsourcing Pharma

OCTOBER 15, 2024

The big pharma company Sanofi has discontinued a phase 2 trial of U.S. partner Denali Therapeuticsâ oditrasertib for the treatment of multiple sclerosis after the drug failed to perform.

Trials 109

Trials Pharma Companies Drugs Clinical Trials 109

Bio Pharma Dive

OCTOBER 28, 2022

Disappointing study results have led the French pharma company to take a $1.6 billion impairment charge and plan new early-stage trials for a drug executives once called a potential “foundation” for newer immunotherapy combinations.

Pharma Companies 193

Pharma Companies Drugs Trials 193

Pharmaceutical Technology

JANUARY 16, 2023

Moreover, Insilico Medicine’s INS018_055, an AI-designed candidate, has produced positive topline results in its Phase I clinical trial for idiopathic pulmonary fibrosis (IPF) treatment. In addition to collaborating with AI-technology providers, pharma companies are also engaging in vertical integration.

Big Data 303

Big Data Pharma Companies Clinical Trials Clinical Trials 303

World of DTC Marketing

JANUARY 11, 2022

Further, 62% of HCPs said that the most significant area where pharma representatives can add value is, by understanding the needs of HCPs and sharing only relevant content with them to make the interactions more insightful. At the same time, marketing emails are among the top 5 channels used by pharma companies to engage HCPs.

Pharma Companies 235

Pharma Companies Sales Marketing Clinical Trials 235

Pharmaceutical Technology

MAY 24, 2024

Shares in the pharma company rose 40% in premarket trading.

Pharma Companies 130

Pharma Companies Trials 130

Pharmaceutical Technology

MARCH 6, 2023

Incannex Healthcare has collaborated with New Jersey-based pharma company Catalent for the development and manufacturing of a cGMP-grade psilocybin drug product for clinical trials and potential commercial use. The latest development follows an internal analysis of the preliminary results of the Phase II PsiGAD clinical trial.

Manufacturing 264

Manufacturing Clinical Trials Clinical Trials Production 264

Pharmaceutical Technology

FEBRUARY 2, 2023

Artificial intelligence (AI) continues to be in the news, and as pharma companies invest more to make sure they’re ahead of the game, international agencies have also started to catch up with regulations for AI-led healthcare research. We also explore how AI is being used to design digital twins for clinical trials.

Gene Therapy 246

Gene Therapy Gene Pharma Companies Clinical Trials 246

pharmaphorum

MARCH 28, 2022

Built under a government tender, AION Labs comprises four large international pharma companies – AstraZeneca , Merck, Pfizer , and Teva – and another core partner, the Israel Biotech Fund. Yerushalmi states there are numerous ways AI can support the pharma process – from clinical trials to patient stratification.

Pharma Companies 98

Pharma Companies Antibody Protein Development 98

pharmaphorum

MARCH 12, 2021

COVID-19 has transformed the way we think about patient participation in trial design – but there are still many barriers to overcome in improving engagement. Speakers at the NIHR’s recent virtual event for the pharma industry discussed best practices for bringing patient insights into research.

Trials 132

Trials Research Pharma Companies Clinical Trials 132

XTalks

DECEMBER 4, 2024

Jupiter Neurosciences, a clinical-stage pharma company specializing in neuroinflammation, made its public market debut with an initial public offering (IPO) on the Nasdaq Capital Market under the symbol “JUNS.” ” The company priced 2,750,000 shares of common stock at $4.00

Bioavailability 111

Bioavailability Genetic Disease Marketing RNA 111

AuroBlog - Aurous Healthcare Clinical Trials blog

APRIL 8, 2024

The Drugs Technical Advisory Board (DTAB) has suggested to the ministry of health and family welfare (MoHFW) to write to the ministry of corporate affairs to mandate the pharma companies to spend almost one per cent of their net profit for providing free medicines in medicine banks as part of the Corporate Social Responsibility (CSR). […]

Medicine 185

Medicine Pharma Companies Drugs Clinical Trials 185

AuroBlog - Aurous Healthcare Clinical Trials blog

MARCH 17, 2024

The Department of Pharmaceuticals (DoP) has issued a new Uniform Code for Pharmaceutical Marketing Practices (UCPMP) 2024, permitting pharma companies to provide brand reminders such as informational and education items and free samples to medical professionals with restrictions on sample packs and total value.

Pharma Companies 189

Pharma Companies Branding Marketing Clinical Trials 189

Intouch Solutions

OCTOBER 13, 2023

Pharmaceutical companies can sponsor as well as provide these leaders. Pharmaceutical companies can increase diversity in their clinical trials. Companies can also support pre-existing SDOH research initiatives. Studies should include as detailed SDOH data as possible.

Pharma Companies 105

Pharma Companies Clinical Trials Clinical Trials Development 105

AuroBlog - Aurous Healthcare Clinical Trials blog

APRIL 11, 2023

The pharma companies’ thrust on R&D to develop better medicines and the demand in hospitals for advanced medical technologies driven by artificial intelligence, remote patient monitoring and wearables are transforming patient care.

Medicine 188

Medicine Development Pharma Companies Clinical Trials 188

AuroBlog - Aurous Healthcare Clinical Trials blog

JANUARY 12, 2023

Indian pharma sees immense value in US FDA’s insistence for aluminum content and labelling recommendations for the Small Volume Parenterals Drug Products and Pharmacy Bulk Packages. Pharma companies in the country have increasingly made a shift to nutritional based prescription and over the counter products.

Packaging 188

Packaging Packaging Pharmacy Pharma Companies 188

Pharmaceutical Technology

JUNE 15, 2023

But before pharmaceutical companies can go to market with a breakthrough drug, they need to ensure safety and efficacy through clinical trials. Pharma R&D teams are solving this problem by leveraging the power of artificial intelligence (AI) in clinical trials to save time and money.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Development 130

AuroBlog - Aurous Healthcare Clinical Trials blog

JULY 11, 2023

The Delhi High Court has granted ten days’ time to the Government of India and the nation’s drug regulator to file a counter affidavit on the petitions filed by almost 28 pharma companies against the order prohibiting manufacturing, distribution and sale of 14 FDCs licensed prior to the year 1988, in the beginning of June. […]

Pharma Companies 186

Pharma Companies Licensing Licensing Sales 186

World of DTC Marketing

NOVEMBER 27, 2020

Pfizer and Moderna have provided data from their large-scale Phase 3 trials only via news releases , which contained the highly promising news that both vaccines were 90 percent effective or more and have not presented any serious safety concerns. The results of trials were announced in press releases rather than peer-reviewed papers.

Vaccine 208

Vaccine Vaccination Pharma Companies Trials 208

AuroBlog - Aurous Healthcare Clinical Trials blog

JULY 16, 2023

At least seven more pharma companies and a federation of pharma manufacturers have approached the Delhi High Court against the Central Government’s order in the beginning of June prohibiting manufacturing, distribution and sale of 14 fixed dose combinations (FDCs) licensed prior to the year 1988.

Pharma Companies 188

Pharma Companies Licensing Licensing Manufacturing 188

pharmaphorum

JANUARY 17, 2022

The adoption of decentralised activities was a major factor in allowing clinical trials to continue during the early stages of the pandemic. Ben Hargreaves examines whether this adoption looks set to become a permanent feature of clinical trials moving into the future, rather than just supplying the tools to a temporary need.

Trials 105

Trials Clinical Trials Clinical Trials Clinical Research 105

World of DTC Marketing

FEBRUARY 7, 2022

At 99% of pharma companies, that's a huge no-no. On top of this, “the company also revealed that the Federal Trade Commission and the Securities and Exchange Commission had opened two new, separate investigations into the troubled biotech. At 99% of pharma companies, that’s a huge no-no.

Pharma Companies 253

Pharma Companies Marketing Sales Clinical Trials 253

pharmaphorum

FEBRUARY 7, 2022

The last three years in pharma have seen a growing awareness of and dissatisfaction with a trend that has plagued the industry for its whole life: Nondiverse and unrepresentative clinical trials, which lead to incomplete data and compounded health disparity for minority populations.

Clinical Trials 96

Clinical Trials Clinical Trials Trials Pharma Companies 96

pharmaphorum

SEPTEMBER 2, 2020

But many patients still do not respond to therapies such as Merck & Co’s anti PD-1 therapy Keytruda (pembrolizumab), or go on to develop progressive disease, and pharma companies are looking for new second-line therapies. A total of 40 patients are planned to be enrolled.

Trials 111

Trials RNA Pharma Companies Clinical Trials 111

pharmaphorum

FEBRUARY 11, 2021

Pharma companies face many challenges when involving patients in the design of clinical trials – but doing so can have huge benefits further down the line, improving the sustainability and quality of research. During the course of my treatments and my trials, and afterwards, I was the expert in how I wanted to manage my life.”.

Clinical Trials 101

Clinical Trials Clinical Trials Trials Clinical Research 101

pharmaphorum

OCTOBER 16, 2020

The trial – run by Boehringer Ingelheim and Yale University – will test a smart bathroom scale device that has cardiac monitoring built in, as well as an app to help patients improve their diet and lose weight and a digital assistant designed to motivate them to actively manage their health. “The

Trials 121

Trials Pharma Companies Development Medicine 121

pharmaphorum

AUGUST 24, 2022

Diversity in clinical trials is a “scientific imperative”, but how can industry bridge the gap between “why” and “how”? Removing barriers to clinical trial participation for underserved groups is an essential part of addressing health inequalities. Clinical trial participation, she went on, was vital. Why, not how.

Clinical Trials 111

Clinical Trials Clinical Trials Trials Development 111

AuroBlog - Aurous Healthcare Clinical Trials blog

FEBRUARY 11, 2025

Yet India needs to develop strategies to mitigate the impact of USAID funding freeze for Indian pharma companies. This is even as a large section of companies exporting to the US noted that even if foreign assistance is […]

Development 146

Development Pharma Companies Drugs Clinical Trials 146

Pharmaceutical Technology

APRIL 13, 2023

Takeda’s announcement underlines the risk associated with gene therapy R&D at the preclinical stage and the fact that many current AAV programs are unlikely to reach late-stage trials. Takeda’s pivot away from AAV gene therapy follows a similar action taken by Pfizer in January 2023 to externalise its gene therapy R&D.

Gene Therapy 243

Gene Therapy Marketing Gene In-Vivo 243

pharmaphorum

JUNE 14, 2022

Despite more treatment options being a positive, Ben Hargreaves finds that this has raised issues over single-region clinical trials, leading to the FDA rejecting certain treatments and clarifying what is required for approval. Only last month , the US company Merck agreed to pay a potential $1.4 Single-region concerns.

Clinical Trials 98

Clinical Trials Clinical Trials Trials Development 98

pharmaphorum

JANUARY 24, 2022

The UK scientists that ran one of the largest trials of experimental COVID-19 drugs have formed a non-profit company that will apply the methodology to other disease areas – with $6.8 ” Those trials also need to be large, involve a diverse range of individuals, and able to be run at reduced cost, said Landray. .

Trials 97

Trials Drugs Clinical Trials Clinical Trials 97

pharmaphorum

NOVEMBER 11, 2022

The lack of diversity in clinical trials has been a topic of debate for decades, but was thrust into the spotlight as the impact of the pandemic on poorer, less educated and ethnically diverse populations became even more apparent. Zeroing in on trials with only US sites is a little more encouraging, but the trends are in the same direction.

Clinical Trials 97

Clinical Trials Clinical Trials Trials Pharma Companies 97

World of DTC Marketing

AUGUST 9, 2021

HCPs don’t necessarily want pharma trying to sell products via social media. The best approach is to use social media to connect HCPs to clincial information and drug trials. A leading pharma company recently sponsored a series of Q&A around the use of their new cancer drug.

Nurses 294

Nurses Marketing Pharma Companies Production 294

pharmaphorum

JULY 8, 2022

The COVID-19 pandemic has catalysed significant changes in the way pharma develops drugs, particularly in the clinical trial space. Hybrid or decentralised clinical trials (DCTs) have gained traction as technology, infrastructure and knowledge have evolved to support their use. Source: Izmailova et al, 2017.

Clinical Trials 100

Clinical Trials Clinical Trials Trials Regulation 100

pharmaphorum

JUNE 11, 2021

A digital therapeutic aimed at people with chronic lower back pain based on virtual reality (VR) has shown encouraging results in a clinical trial, helping patients manage the fear of movement that can reduce their activity and impede recovery. The post Trial finds Orion digital therapeutic helps chronic pain sufferers appeared first on.

Trials 130

Trials Medicine Development Pharma Companies 130

pharmaphorum

FEBRUARY 1, 2022

Across the industry, pharma companies are turning to AI and real-world data to address many of the challenges of running clinical trials. Can the combined potential of new AI technologies and real-world patient data hold the key to overcoming the challenges in clinical trial design that have historically led to trial failure?

Clinical Trials 104

Clinical Trials Clinical Trials Trials Engineer 104

pharmaphorum

SEPTEMBER 11, 2020

Yet, for clinical trials worldwide, real-time access to data is not the norm – and that lack can create a cascading set of issues affecting every aspect of a study. What does this mean for clinical trials? Analysts at Pharma Intelligence decided to find out, surveying professionals involved in clinical data management.

Trials 98

Trials Clinical Trials Clinical Trials Pharma Companies 98

pharmaphorum

JANUARY 10, 2025

A major population proteomics study using UK Biobank patient samples backed by 14 pharma companies has launched today.

Biobanking 80

Biobanking Pharma Companies Trials 80